| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10965700 | Vaccine | 2015 | 9 Pages |
Abstract
In this study of healthy adults aged 50-85 and 18-24 years, SA3Ag elicited a rapid and robust immune response and was well tolerated, with no notable safety concerns.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Michael Nissen, Helen Marshall, Peter Richmond, Sepehr Shakib, Qin Jiang, David Cooper, Denise Rill, James Baber, Joseph Eiden, William Gruber, Kathrin U. Jansen, Emilio A. Emini, Annaliesa S. Anderson, Edward T. Zito, Douglas Girgenti,